Advertisement

NLS Business

Business - February 1, 2023

Last patient included in AlzeCure’s Phase II trial

The last patient has now been included in the ongoing clinical study with ACD440, the lead non-opioid drug candidate in the painless platform, which is being developed against peripheral neuropathic pain. This double-blind, placebo-controlled, randomized cross-over study, which is carried out in collaboration with LINK Medical Research in Uppsala, is aimed at evaluating the efficacy, […]

Business - February 1, 2023

An export success anchored in Umeå & Linköping

Nordic Biomarker was recently named ‘Exporter of the Year 2022’ but the Umeå-based company says its journey has only just begun. The company has announced its vision to become a global force in the life science industry – with an ambitious five-year goal to reach almost a 1 billion SEK turnover and potentially employ over […]

Business - January 25, 2023

A high-level take on recent trends in healthcare

Healthcare stock indices enjoyed a decade-long growth-phase until and including 2017. IPOs within the sector, at arguably far too steep valuations, continued riding on this growth phase, peaking somewhat later in 2020-2021. This phase culminated with a growing number of disappointments between 2020-1H 2022, driven first by gene therapies, then oncology and in neurodegenerative diseases. […]

Business - January 18, 2023

A hotbed for innovation and technology

The new science city in Reykjavik is set to attract growing companies, foreign investors and even more talent. Despite being one of the world’s smallest capitals, Reykjavik has an innovative and creative atmosphere, not least within life sciences. The life science industry includes biotech, pharma, genetics, and medical devices, and it is a growing sector […]

Business - January 13, 2023

Strategies for business growth

What are the secret ingredients for successful company growth within life sciences? What lessons can we learn from the journeys, progress, setbacks and challenges of other Nordic companies? What perspectives and advice can the region’s investors and business advisors provide? The pandemic’s impact on life and businesses is slowly coming to an end, at least […]

Business - January 12, 2023

She is the new CEO of Oncopeptides

The Board of Directors of the company has appointed Monica Shaw as Chief Executive Officer, CEO, of Oncopeptides. Shaw replaces Jakob Lindberg, who has been the CEO since November 15, 2021. Lindberg assumes his previous position as Chief Scientific Officer. A transformational year The leadership changes follow a transformational year for Oncopeptides, when Pepaxti, was […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.